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Abstract 
Background: Animal data demonstrate associations of dioxin, furan, and PCB exposures with 
altered male gonadal maturation.  It is unclear whether these associations apply to human 
populations. 
Objectives:  We investigated the association of dioxins, furans, PCBs and corresponding toxic 
equivalent (TEQ) concentrations with pubertal onset among boys in a dioxin-contaminated 
region. 
Methods:  Between 2003-2005, 489 boys were enrolled at ages 8-9 years in a longitudinal study 
in Chapaevsk, Russia.  Pubertal onset  – stages 2 or higher for genitalia (G2+) or testicular 
volume (TV) > 3 ml – was assessed annually between ages 8-12 years.  Serum levels at 
enrollment were analyzed by the Centers for Disease Control and Prevention, Atlanta, GA.  Cox 
proportional hazards models were used to assess age at pubertal onset as a function of exposure 
adjusted for potential confounders.  Sensitivity analyses were conducted excluding boys with 
pubertal onset at enrollment.   
Results:  The median (range) total serum TEQ concentration was 21 (4-175) pg/g lipid, 
approximately three times higher than values in European children. At enrollment, boys were 
generally healthy and normal weight (mean BMI 15.9 kg/m2), with 30% having entered puberty 
by G2+ and 14% by TV criteria.  Higher dioxin TEQs were associated with later pubertal onset 
by TV, hazard ratio = 0.68, 95% CI: 0.49-0.95 for the highest compared with the lowest quartile. 
Similar associations were observed for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and dioxin 
concentrations for TV but not G2+.  Results were robust to sensitivity analyses. 
Conclusions:  Findings support an association of higher peri-pubertal serum dioxin TEQs and 
concentrations with later male pubertal onset reflected in delayed testicular maturation.   
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Introduction  
 The transition from pre-puberty to sexual maturity entails rapid physical, hormonal, and 
behavioral development.  Alterations in the timing of pubertal onset or pace of its progression 
can adversely impact not only physical and sexual maturation but also social, cognitive and 
behavioral development as well as adult health (Graber et al. 2004; Michaud et al. 2006).  For 
example, earlier puberty incurs risk for metabolic syndrome and obesity in later life and delayed 
puberty is associated with decreased bone mineral density in adults raising concerns about 
increased fracture risk (Biro et al. 2003; Finkelstein et al. 1996; Van Lenthe et al. 1996).   
 In recent decades, suggestive evidence of earlier onset of breast development and age at 
menarche has been observed in girls but data in boys are limited (Biro et al. 2010; Euling et al. 
2008; Herman-Giddens et al. 1997; Herman-Giddens et al. 2001; Sorensen et al. 2010).  
Explanations for this possible trend include changes in diet and activity, and environmental 
exposures.  Chemicals that can disrupt gonadal steroidogenesis and neuroendocrine pathways, 
such as organochlorine pollutants including dioxins, furans, and polychlorinated biphenyls 
(PCBs), are of particular concern (Jacobson-Dickman and Lee 2009; Schoeters et al. 2008).    
Despite efforts to limit dioxin emissions, and longstanding bans on PCB manufacture and use, 
human exposure is ongoing, primarily through diet.  For example, fish and dairy are potential 
exposure sources due to organochlorines’ lipophilic properties, long half lives, on the order of 
years to decades, and propensity to bioconcentrate (Schecter et al., 2001).   
 Gestational or lactational dioxin exposures in animals have been consistently associated 
with delayed male pubertal onset (Bell et al. 2007; Hamm et al. 2003; Theobald et al. 2003).  
However, the few human epidemiologic studies of organochlorine exposures and puberty in boys 
did not examine onset and had inconsistent findings.  Where direct exposure biomarkers were 
used, dioxins, furans or PCBs were associated with no differences in (Den Hond et al. 2002; 
Gladen et al. 2000; Leijs et al. 2008) or earlier (Den Hond et al. 2010) male genital maturation 
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among older adolescents but inferences were often limited by small sample sizes (Den Hond et 
al. 2002; Leijs et al. 2008).   
 Chapaevsk, Russia is an industrial town contaminated with dioxins consequent to past 
production of chemical warfare agents and recent production of chlorinated chemicals.  Waste 
from these industries resulted in pervasive dioxin contamination of soils, water, and local food 
(Revich et al. 1999; Sergeyev et al. 2007).  Community concerns regarding potential health 
hazards from this contamination led to a study of dioxins and male pubertal development.  
 
Materials and Methods 
Study Population  
 The Chapaevsk study is an ongoing prospective study of 499 generally healthy boys 
(Hauser et al. 2008).  All (n=623) eight- to nine-year-old male residents were identified between 
2003 and 2005 using health insurance records and the town’s clinic system.  Of these, 572 met 
eligibility criteria and 516 (90%) agreed to participate.  Children were ineligible if their address 
was unavailable, if they were likely to move during the study, or if they had severe cerebral 
palsy.  After enrollment, 17 children living in orphanages were excluded because of missing 
birth or family history.  For this analysis, 10 additional boys were excluded for chronic illnesses 
that could affect growth – for example, severe asthma or malignancy – leaving 489 boys.      
 Once enrolled, each boy underwent a physical examination, provided a blood sample, 
and, with his mother/guardian, completed health, lifestyle and dietary questionnaires.  Annual 
follow up examinations were conducted on or close to each boy’s birthday and questionnaires 
updated.  For this analysis, three years of follow-up data were available with each boy observed 
up to four times between 8 to 11, or 9 to12 years.  
 The study was approved by the Human Studies Institutional Review Boards of the 
Chapaevsk Medical Association (Chapaevsk, Russia); Harvard School of Public Health and 
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Brigham and Women’s Hospital (Boston, MA), and University of Massachusetts Medical School 
(Worcester, MA). The parent/guardian signed an informed consent and each boy signed an 
assent prior to participation. 
Growth and Pubertal Assessment:   
 At annual visits, an endocrinologist (OS, with a nurse present) conducted standardized 
physical examinations without knowledge of the boy’s exposure.  Examination included 
measurement of height in stocking feet (to the nearest 0.1 cm) using a fixed arm stadiometer and 
weight in underclothes (to the nearest 100 gm) using a balance scale.  Body mass index (BMI; 
kg/m2) was calculated from measured height and weight.   Pubertal maturation was graded from 
1 to 5 by visual inspection according to established criteria (Tanner and Whitehouse 1976).  
Testicular volume (TV) was measured using an orchidometer.  Pubertal onset was defined as 
stages 2 or higher for genitalia (G2+) or testicular volume (TV) > 3 ml for either testis.   
Questionnaire Assessment: 
 At enrollment, each mother/guardian completed a nurse-administered questionnaire 
ascertaining the child’s birth and medical history, breastfeeding status, physical activity; family 
demographics, income, residential history; and parental reproductive and medical history, 
occupation, education, smoking and alcohol consumption.  Birth weight and gestational age were 
obtained from medical record review.  Diet was ascertained using a food frequency questionnaire 
modified from a validated Russian Institute of Nutrition instrument (Burns et al. 2009; 
Martinchik et al. 1998).   
Organochlorine Exposure Assessment:   
 Fasting blood samples were collected prior to baseline examination and the serum 
fraction was stored at -35oC until shipment for analysis at the National Center for Environmental 
Health at the Centers for Disease Control and Prevention, Atlanta, GA.  Analytes included 7 
polychlorinated dibenzo-p-dioxins (PCDDs or dioxins), 10 polychlorinated dibenzofurans 
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(PCDFs or furans), 4 co-planar polychlorinated biphenyls (co-PCBs), 6 mono-ortho substituted 
PCBs, and 31 other PCBs (non-dioxin-like PCBs) described in Burns et al. (2009).   
 For dioxin-like analytes, sera, method blanks, and quality control samples (aliquots of 
pooled bovine sera) were spiked with a mixture of 13C12-labeled PCDDs/PCDFs and co-PCBs as 
internal standards and serum analytes were isolated by solid phase extraction (SPE) followed by 
a multicolumn automated cleanup and enrichment procedure (Turner et al. 1997).  Analytes were 
separated on a DB-5 MS capillary column and quantified using selected-ion-monitoring (SIM) 
high resolution (10,000 resolving power) mass spectrometry (HRGC-ID/HRMS) (Patterson et al. 
1987).  Quantification by isotope dilution mass spectrometry used calibration standards 
containing 13C12-labeled, and unlabeled analytes.    
 A similar approach was used for mono-ortho and non-dioxin-like PCBs (Barr et al. 
2003).  Samples were spiked with 13C12-labeled PCBs, extracted by either large (Turner et al. 
1997) or small (Sjordin et al. 2004) volume SPE, and analyzed using high resolution GC/MS in 
SIM (Barr et al. 2003).   
 For all analytes, quality control sample coefficients of variation (CVs) combining 
between and within run reproducibility were generally below 15%.  All concentrations were 
expressed on a per lipid basis with serum total cholesterol and triglycerides measured 
enzymatically, and total lipids calculated using the Phillips equation (Phillips et al. 1989). 
Congener concentrations below the limit of detection (LOD) were assigned the LOD divided by 
the square root of 2. 
Statistical Analysis:   
Dioxin toxic equivalents (TEQs) were computed on a lipid basis using the 2005 WHO 
toxic equivalency factors (TEFs) to weight each congener’s potency relative to 2,3,7,8-
tetrachlorodioxin (TCDD) prior to summation (Van den Berg et al. 2006).  Nine different 
exposure measures were considered:  (1) total (summed) TEQ measures (pg/g lipid) for 
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combined dioxin, furan, co-PCB, and mono-ortho PCB congeners; (2) TCDD (pg/g lipid); (3-5) 
total (summed) TEQs  (pg/g lipid) for each of dioxins, furans, and co-PCBs; (6-8) total 
(summed) concentrations (pg/g lipid) for each of dioxins, furans and co-PCBs; and (9) total 
(summed) concentrations of non-coplanar PCBs, including mono-ortho-substituted PCBs 
(ΣPCBs, ng/g lipid).  Organochlorine measures were categorized into quartiles because of 
potential non-linear associations.  Analyses were repeated using a quartile indicator (1, 2, 3, 4) 
for exposure to test for trend across quartiles.  Statistical significance was defined as a p-value < 
0.05.   
  Standard Cox proportional hazards models were used to assess time to pubertal onset as 
a function of exposure adjusted for potential confounders.  Age of pubertal onset was assigned to 
the midpoint between age at the previous visit and age at the visit at which onset was noted.   For 
boys in puberty at study enrollment (n=141 by G2+; n=66 by TV>3 ml), age at onset was 
defined as 6 months prior to age at enrollment.  Observations were censored at the last visit for 
boys not yet in puberty.  
 Sensitivity analyses were performed using both interval censored likelihood-based 
models and repeated measures generalized estimating equation (GEE) models. The interval 
censored approach does not assign a specific time of onset, but instead assumes that pubertal 
onset occurred in the interval between study visits.  This approach was used to estimate overall 
mean age of pubertal onset, assuming a normally distributed age at onset, and mean age at 
pubertal onset for each exposure quartile, adjusted for confounders.  The GEE approach was 
used to fit a logistic regression model for pubertal onset at each visit as a function of age at visit, 
with adjustment for potential confounders and correlation among multiple visits via an 
autoregressive structure.  GEEs were also used to evaluate the impact of clustering within 
household for twins (4 pairs) and siblings (3 pairs). To account for possible examiner and 
laboratory drift over time, uncertainty regarding  age of pubertal onset, and the potential for 
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reverse causation (due to dilution of dioxin concentrations in larger, more mature boys), 
additional sensitivity analyses were performed excluding boys with pubertal onset at study entry 
and adjusting for year of organochlorine analysis. 
 Covariates considered in models included potential determinants of pubertal onset:   
child’s age at exam, birthweight, gestational age, breastfeeding; nutrition, height, weight, and 
BMI at enrollment; household income; maternal age at birth and parity; prenatal smoking (active 
and second hand) and alcohol intake; parental education; and blood lead (Williams et al. 2010).  
A core model was developed by first assessing the univariate relation of covariates to each 
pubertal onset measure and retaining those with a p-value <0.20.  Covariates meeting this 
criterion were included in a ‘full’ model and then backward selection (likelihood ratio test) was 
used to iteratively exclude the least important covariates (retain p<0.15).  Covariates were 
retained if they were significant for at least one pubertal onset measure, or if they resulted in a 
10% or greater change in exposure effect estimates when added, one at a time, into our final 
model. Because height and BMI at enrollment may be proxies for pubertal onset or on the causal 
pathway relating dioxins with onset, sensitivity analyses were performed excluding these 
covariates from the final model.   As mother’s age at menarche was missing for 8% of 
participants, this covariate was added to the final models in sensitivity analyses.  
 The association of pubertal onset with each of the nine different exposure measures was 
assessed, one exposure at-a-time.  These nine measures were moderately to strongly correlated 
(Spearman r = 0.44-0.90) so secondary analyses were performed to assess the independent 
relation of dioxin-like versus non-dioxin-like exposures with pubertal onset.  Specifically, final 
models for the relation of each dioxin-like measure (total TEQ, TCDD, as well as dioxin, furan, 
and co-PCB TEQ and concentration measures) with pubertal onset were re-run with non-
coplanar PCB concentrations (ΣPCBs) added to the models.   
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Results 
Demographic and exposure characteristics:   
 The boys were racially homogeneous (all Caucasian) and most were full term with 
normal birth weight and enrollment BMI (Table 1).  Of the 489 boys, 473 had dioxin/furan 
measures and 468 had PCB measures.  The median (range) total serum TEQs at 8-9 years was 
21.1 (4.0 to 174.7) pg/g lipid, about three times higher than levels among similar aged European 
children (Table 2) (Leijs et al. 2008; Link et al. 2005).    
Pubertal onset characteristics:    
 Most (85%) boys had four annual examinations between ages 8-11 or 9-12 with 6%, 4%, 
and 5%, respectively, examined three times, twice or once.   At study entry (both 8- and 9-year-
olds), 30% had entered puberty by G2+ and 14% by TV criteria.  By age 12, most had entered 
puberty (92% by G2+ and 83% by TV criteria).  Overall, the estimated mean (95% CI) age of 
onset by G2+ and TV, based on interval censored models, was 9.4 (9.2, 9.6) and 10.5 (10.3, 
10.7) years, respectively.  In multivariable models (results not shown), pubertal onset was 
significantly earlier with higher birth weight (both measures), lower gestational age (G2), higher 
percentage of dietary fat (TV), and greater height or BMI at the initial study visit (both 
measures).   Conversely, pubertal onset was significantly later with maternal alcohol 
consumption during pregnancy (TV), low household income (TV), older maternal age at 
menarche (both measures), and high blood lead (both measures).  
Association of dioxins, furans, and PCBs with pubertal onset:   
 In multivariable Cox proportional hazards models, pubertal onset was later with 
increasing dioxin exposure for TV but not G2+ (Table 3; Figure 1).   For example, for TV > 3ml, 
the hazard ratio (HR) was 0.69, 95% CI: 0.48, 0.98 for the highest compared with the lowest 
quartile of serum TCDD; similar associations were observed for PCDD TEQs (Table 3; Figure 
1).  There was suggestive evidence of later pubertal onset (TV) with increasing PCDF or co-PCB 
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concentrations but not with PCDF TEQs, co-PCB TEQs, or ΣPCB levels (Table 3; Figure 1).  
Similar findings were observed in adjusted interval censored models; for example, TCDD was 
associated with approximately 5½ months’ later onset (TV) for the highest compared with lowest 
quartile of serum levels (95% CI: -0.6, 11.9; p trend = 0.07) (Supplemental Material, Table 1).   
 In sensitivity analyses, the observed associations of dioxins with later pubertal onset by 
TV criteria were similar in GEE models and, in Cox models, were essentially unchanged after 
inclusion of maternal age at menarche, excluding boys who were pubertal at enrollment, 
excluding twins and siblings, or adjusting for year of serum analyses.  However, adjustment for 
enrollment height and BMI attenuated the findings.  For example, for onset by TV, the 4th (vs. 
1st) quartile HR for total TEQs or PCDF TEQs, respectively, were 0.75 (95% CI: 0.54, 1.05; p-
trend=0.08) and 0.76 (95% CI: 0.54, 1.09; p-trend=0.12)  without height and BMI adjustment 
compared with 0.81 (95% CI: 0.58, 1.15; p-trend=0.19) and 0.86 (95% CI: 0.60, 1.24; p-
trend=0.32) with adjustment (Table 3).    
 Adjusting models for ΣPCB levels resulted in slightly stronger associations of dioxin-like 
measures with later onset by TV (Supplemental Material, Table 2).   For example, the 4th (vs. 1st) 
quartile HR for total TEQs was 0.63 (95% CI: 0.38, 1.06; p-trend=0.07) compared with 0.81 
(95% CI: 0.58, 1.15; p-trend=0.19) without adjustment for ΣPCBs.  Although the association of 
dioxin-like exposure measures with onset by G2+ remained largely non-significant, these 
associations were also stronger for most exposure measures after adjustment for ΣPCB levels 
(Supplemental Material, Table 2).  For example, the 4th (vs. 1st) quartile HR for total TEQs was 
0.66 (95% CI: 0.41, 1.05; p-trend=0.12) compared with 0.91 (95% CI: 0.67, 1.23; p-trend=0.77)  
without ΣPCB adjustment.   
 ΣPCB levels were not associated with pubertal onset in the primary study analyses (Table 
3), but secondary analyses, although mostly non-significant, supported a tendency for earlier 
pubertal onset by both TV and G2+ criteria with increasing ΣPCBs in models adjusted for 
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dioxin-like measures (Supplemental Material, Table 3).  For example, the 4th (vs. 1st) quartile HR 
for ΣPCBs (adjusted for total TEQs), was 1.41 (95% CI: 0.82, 2.42; p-trend=0.23) for onset by 
TV and 1.51 (95% CI: 0.94, 2.43; p-trend=0.08) for onset by G2+.   
 
Discussion 
 This is perhaps the only, large prospective cohort study of the relation of serum peri-
pubertal dioxins, furans and PCBs with physician assessed male pubertal onset.  The results 
demonstrate a relation of peri-pubertal dioxin exposure measures with subsequent delays in 
testicular maturation.    Study results are consistent with animal models in which delayed male 
pubertal onset, assessed by genital maturation, is a consistently demonstrable correlate of early 
life dioxin exposure (Bell et al. 2007; Hamm et al. 2003; Theobald et al. 2003).  
 In contrast, findings have been inconsistent among previous epidemiologic studies that 
examined late pubertal milestones rather than pubertal onset (potentially a more sensitive 
endpoint) and have been limited either by small sample size, cross-sectional design, self-reported 
pubertal staging, or lack of an exposure biomarker.  For example, 80 Belgian teenage boys living 
near an incinerator (a presumed dioxin exposure source) had later sexual maturity, including 
smaller TV, compared with boys in an unpolluted town but TV did not correlate with indirect 
(CALUX assay) measures of dioxin exposure (Den Hond et al. 2002). Conversely, in a large 
(n=887) cross-sectional study of 14- to 15-year-old Belgian boys, serum organochlorine levels 
(PCBs, p,p’-DDE, and hexachlorobenzene) were associated with earlier genital development 
(increased odds of G3) on routine school health examinations performed, on average, within 
about one month of serum collection (Den Hond et al. 2010).  Biomarkers of dioxin exposure 
were not assessed but the PCB findings are consistent with our secondary analyses suggestive of 
possible earlier pubertal onset with increasing PCB exposures (Supplementary Material, Table 
3).  Among 14- to 18-year-old Dutch boys, pubertal maturation, including TV, was not 
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associated with perinatal or concurrent dioxin levels but there were only 15 boys in this study 
and, as with the Belgian studies, assessments focused on late stages of puberty (Leijs et al. 2008). 
Lastly, among 244 (primarily 12- to 14-year-old) North Carolina boys, age of self-reported 
pubertal stages was not associated with measures of prenatal PCB or DDE exposure (Gladen et 
al. 2000).  Although larger than most other studies, the North Carolina assessments did not 
include measures of dioxin, TV, or pubertal onset.  
 Several potential limitations impact interpretation of study findings.  First, although both 
TV and G2+ maturation reflect hypothalamic-pituitary-gonadal (HPG) activation, associations 
were observed for TV but not genital staging (Table 3) with suggestive but mostly non-
significant G2+ delays observed in association with dioxin-like measures only after adjustment 
for ΣPCBs.   Assessment of TV by palpation and comparison with a standardized orchidometer  
is considered a more precise measure of gondal development and pubertal status than genital 
staging (Biro et al. 1995; Euling et al. 2008) with minimal intraobserver variability (Carlson et 
al., 2000) which could account for its greater sensitivity.   In addition, testicular growth reflects 
both luteinizing hormone (LH) and follicle stimulating hormone (FSH) stimulation and paracrine 
androgen actions whereas penile and scrotal maturation (G2) are primarily influenced by 
circulating androgens (Macleod et al. 2010; Raivio et al. 2007).    In animal models, early life 
dioxin exposure inhibits androgen biosynthesis and disrupts the HPG axis (Clements et al. 2009; 
Cooke et al. 1998; Fukuzawa et al. 2004; Kakeyam et al. 2008). If dioxins disproportionately 
impair gonadotropin secretion relative to androgen biosynthesis, TV could be affected more than 
G2.    
 Although the boys’ mean age of pubertal onset by TV (10.5 years) is consistent with 
other studies (Herman-Giddens et al. 2001; Susman et al. 2010), later onset has been observed in 
Danish boys (Sorensen et al. 2010) and Chapaevsk boys’ mean age of onset by G2 (9.4 years) is 
younger than reported elsewhere.  Whether the apparent earlier G2 reflects a true difference 
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between Chapaevsk boys and other populations is unclear as most data on male pubertal 
development is cross-sectional and/or collected at older ages (Biro et al. 1995; Sun et al. 2005; 
Susman et al. 2010) making comparisons difficult.  But, given that study exams were all 
performed by a single physician, internal comparisons among study boys should be valid and 
unbiased.   
 Additional study limitations include the observation that a number of Chapaevsk boys 
had entered puberty prior to study enrollment (e.g., 12% of 8-year-olds and 18% of 9-year-olds 
by TV); it is unclear whether exposure measures obtained after pubertal onset reflect relevant 
exposure risk.  However, the relationship of dioxins with TV persisted after exclusion of boys in 
puberty at enrollment.  Although lower BMI and socioeconomic status were associated with both 
higher serum dioxins and later pubertal onset in this cohort (Burns et al. 2009) and thus may 
confound results,  the relationship of dioxins with TV persisted after adjustment for height, BMI, 
and measures of socioeconomic status (Table 3).   
 Lastly, if dioxin-associated alterations in male pubertal development are aryl 
hydrocarbon receptor (AhR) mediated toxicities (Theobald et al. 2003), then the apparent 
stronger association of TV with PCDD TEQs compared to PCDF or co-PCB TEQs is difficult to 
explain.  It is possible that non-AhR-mediated mechanisms are relevant (Butler et al. 2004) and 
congeners contributing to such mechanisms correlate better with some TEQ measures than 
others.  Also, sources of environmental contamination with PCDDs, PCDFs or PCBs may vary, 
as the latter are a manufactured product rather than a byproduct of chemical production or 
incineration.  Thus, confounding by differing unmeasured co-occurring exposures may explain 
apparent differential TEQ effects.  The results of secondary analyses suggestive of  earlier, rather 
than later, puberty in association with non-co-planar PCB exposures, are consistent with the 
possibility that non-AhR-related mechanisms may be important to organochlorine-associated 
alterations in male pubertal onset.   Although Taiwanese boys with substantial prenatal furan and 
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PCB exposure, had no apparent exposure-associated differences in pubertal stage (Hsu et al. 
2005), concurrent PCB levels have been associated with earlier, not later, male genital 
development in other populations (Den Hond et al. 2010).    
 
Conclusions 
 Although recent emphasis has been placed on environmental risk factors for earlier breast 
development and menarche in girls, environmental contaminants may also delay puberty 
(Selevan et al. 2003; Wu et al. 2003) and impact puberty in boys.  In the present study, serum 
dioxins measured at age 8 or 9 years were associated with later male pubertal onset (by TV 
criteria).  Although this was not indicative of clinically delayed onset, modest changes in the 
mean value of a health indicator, such as pubertal onset, can signal substantial changes in the 
prevalence of clinically evident disease within a population (Korrick and Bellinger 2007).  
Page 16 of 28
 17 
References 
 
Barr JR, Maggio VL, Barr DB, Turner WE, Sjodin A, Sandau CD, et al.  2003. New high-
resolution mass spectrometric approach for the measurement of polychlorinated biphenyls and 
organochlorine pesticides in human serum.  J Chromatogr B 794:137-148.  
 
Bell DR, Clode S, Fan MQ, Fernandes A, Foster PM, Jiang T, et al. 2007.  Toxicity of 2,3,7,8-
tetrachlorodibenzo-p-dioxin in the developing male Wistar(Han) rat II: chronic dosing causes 
developmental delay. Toxicol Sci 99:224-233. 
 
Biro FM, Galvez MP, Greenspan LC, Succop PA, Vangeepuram N, Pinney SM, et al. 2010.  
Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls.   
Pediatrics 126:e583-e590. 
 
Biro FM, Lucky AW, Huster G, Morrison JA.  1995. Pubertal staging in boys.  J Pediatr  
127:100-102. 
 
Biro FM, Lucky AW, Simbartl LA, Barton BA, Daniels SR, Striegel-Moore R, et al. 2003. 
Pubertal maturation in girls and the relationship to anthropometric changes: pathways through 
puberty.  J Pediatr 142:643-646. 
 
Burns JS, Williams PL, Sergeyev O, Korrick S, Lee MM, Revich B, et al.  2009. Predictors of 
serum dioxins and PCBs among peripubertal Russian boys.  Environ Health Perspect 117:1593-
1599.  
 
Butler RA,  Kelley ML, Olberding KE, Gardner GR, Van Beneden RJ. 2004. Aryl hydrocarbon 
receptor (AhR)-independent effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on softshell 
clam (Mya arenaria) reproductive tissue.  Comp Biochem Physiol C Toxicol Pharmacol 
138:375-381. 
 
Carlsen E, Andersen AG, Buchreitz L, Jorgensen N, Magnus O, Matulevicuus V, et al.  2000.  
Inter-observer variation in the results of the clinical andrological examination including 
estimation of testicular size.  Int J Androl 23:248-253. 
Page 17 of 28
 18 
 
Clements RJ, Lawrence RC, Blank JL.  2009. Effects of intrauterine 2,3,7,8-tetrachlorodibenzo-
p-dioxin on the development and function of the gonadotropin releasing hormonal neuronal 
system in the male rat.  Reprod Toxicol 28:38-45. 
 
Cooke GM, Price CA, Oko RJ.  1998. Effects of in utero and lactational exposure to 2,3,7,8-
terachlorodibenzo-p-dioxin (TCDD) on serum androgens and steroidogenic enzyme activities in 
the male rat reproductive tract.  J Steroid Biochem Molec Biol 67:347-354. 
 
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. 2007. Development of a 
WHO growth reference for school-aged children and adolescents.   Bull World Health Organ 
85:660-667. 
 
Den Hond E, Dhooge W, Bruckers L, Shoeters G, Nelen V, van de Mieroop E, et al. 2010.  
Internal exposure to pollutants and sexual maturation in Flemish adolescents.  J Expo Sci 
Environ Epidemiol; doi:10.1038/jes.2010.2 [Online 3 March 2010]. 
 
Den Hond E, Roels HA, Hoppenbrouwers K, Nawrot T, Thijs L, Vandermeulen C, et al. 2002. 
Sexual maturation in relation to polychlorinated aromatic hydrocarbons:  Sharpe and 
Skakkebaek’s hypothesis revisited.  Environ Health Perspect 110:771-776. 
 
Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sorensen TIA, et al. 2008. 
Examination of U.S. puberty-timing data from 1940 to 1994 for secular trends: panel findings.  
Pediatrics121 (suppl 3): S172-S191. 
 
Finkelstein JS, Klibanski A, Neer RM. 1996.  A longitudinal evaluation of bone mineral density 
in adult men with histories of delayed puberty.  J Clin Endocrinol Metab 81:3812-3813. 
 
Fukuzawa NH, Ohsako S, Wu Q, Sakaue M, Fujii-Kuriyama Y, Baba T, et al. 2004. Testicular 
cytochrome P450scc and LHR as possible targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) in the mouse.  Mol Cell Endocrinol 221:87-96. 
 
Page 18 of 28
 19 
Gladen BC, Ragan B, Rogan WJ. 2000. Pubertal growth and development and prenatal and 
lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene.  J Pediatr 
136:490-496. 
 
Graber JA, Seelely JR, Brooks-Gunn J, Lewinsohn PM. 2004. Is pubertal timing associated with 
psychopathology in young adulthood.  J Am Acad Child Adolesc Psychiatry 43:718-726. 
 
Hamm JT, Chen CY, Birnbaum LS. 2003. A mixture of dioxins, furans, and non-ortho PCBs 
based upon consensus toxic equivalency factors produces dioxin-like reproductive effects.  
Toxicol Sci 74:182-191. 
 
Hauser R, Sergeyev O, Korrick S, Lee MM, Revich B, Gitin E, et al. 2008. Association of blood 
lead levels with onset of puberty in Russian boys.  Environ Health Perspect116:976-980. 
 
Herman-Giddens ME, Slora EJ, Wasserman RC,  Bourdony CJ, Bhapkar MV, Koch GG, et al.  
1997. Secondary sexual characteristics and menses in young girls seen in office practice: a study 
from the Pediatric Research in Office Settings network.  Pediatrics 99:505-512. 
 
Herman-Giddens ME, Wang L, Koch G. 2001. Secondary sexual characteristics in boys: 
estimates from the National Health and Nutrition Examination Survey III, 1988-1994. Arch 
Pediatr Adolesc Med 155:1022-1028. 
 
Hsu PC, Lai TJ, Guo NW, Lambert GH, Guo YL. 2005. Serum hormones in boys prenatally 
exposed to polychlorinated biphenyls and dibenzofurans.  J Toxicol Environ Health, Part A 
68:1447-1456. 
 
Jacobson-Dickman E, Lee MM. 2009. The influence of endocrine disruptors on pubertal timing.  
Curr Opin Endocrinol Diabetes Obes 16:25-30. 
 
Kakeyama M, Sone H, Tohyama C.  2008.  Perinatal exposure of female rats to 2,3,7,8-
tetrachlorodibenzo-p-dioxin induces central precocious puberty in the offspring.  J Endocrinol 
197:351-358. 
 
Page 19 of 28
 20 
Korrick SA, Bellinger DC.  2007. Invited commentary: persistent organic pollutants and 
childhood learning and behavioral disorders.  J Epidemiol Community Health 61:564-565. 
 
Leijs MM, Koppe JG, Olie K, van Aalderen WMC, de Voogt P, Vulsma T, et al. 2008.  Delayed 
initiation of breast development in girls with higher prenatal dioxin exposure; a longitudinal 
cohort study. Chemosphere 73:999-1004. 
 
Link B, Gabrio T, Zoellner I, Piechotowski I, Paepke O, Herrmann T, et al. 2005. Biomonitoring 
of persistent organochlorine pesticides, PCDD/PCDFs and dioxin-like PCBs in blood of children 
from southwest Germany (Baden-Wuerttemberg) from 1993-2003.  Chemosphere 58:1185-1201. 
 
Macleod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchison GR, et al.  2010.  Androgen 
action in the masculinization programming window and development of male reproductive 
organs.  Int J Androl 33:279-287. 
 
Martinchik AN, Baturin AK, Baeva VS,  Feoktistova AI, Piatnitskaia IN, Azizbekian BA, et al. 
1998. [Development of a method of studying actual nutrition according to analysis of the 
frequency of consumption of food products: creation of a questionnaire and general evaluation of 
the reliability of the method] [in Russian].  Vopr Pitan 3:8-13. 
 
Michaud PA, Suris JC, Deppen A. 2006. Gender-related psychological and behavioural 
correlates of pubertal timing in a national sample of Swiss adolescents.  Molecular and Cellular 
Endocrinology 254-255:172-178. 
 
Patterson DG Jr, Hampton L, Lapeza CR Jr,  Belser WT, Green V, Alexander L, et al. 1987. 
High-resolution gas chromatographic/high-resolution mass spectroscopic analysis of human 
serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin.  Anal Chem 
59:2000-2005. 
 
Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, Needham LL. 1989. 
Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding.  Arch Environ 
Contam Toxicol 18:495-500. 
 
Page 20 of 28
 21 
Raivio T, Wikstrom AM, Dunkel L.  2007. Treatment of gonadotropin-deficient boys with 
recombinant human FSH:  long-term observation and outcome.  Eur J Endocrinol 156:105-111. 
 
Revich B, Brodsky E, Sotskov Y. 1999. Dioxin in environmental, blood, breast milk, cow milk 
in Chapaevsk town.  Organohalogen Compounds 44:229-232. 
 
Schecter A, Cramer P, Boggess K, Stanley J, Papke O, Olson J, et al. 2001. Intake of dioxins and 
related compounds from food in the U.S. population.  J Toxicol Environ Health A 63:1-18. 
 
Schoeters G, Den Hond E, Dhooge W, van Larebeke N, Leijs M. 2008. Endocrine disruptors and 
abnormalities of pubertal development.  Basic Clin Pharmacol Toxicol 102:168-175. 
 
Selevan SG, Rice DC,  Hogan KA, Euling SLY, Pfahles-Hutchens A, Bethel J. 2003. Blood lead 
concentration and delayed puberty in girls.  N Engl J Med 348:1527-1536. 
 
Sergeyev O, Saharov I, Shelepchikov AA, Revich B, Sotskov Y, Brodsky E, et al. 2007.  Levels 
of PCDDs/PCDFs in the environment and food after 3 years of full plant inactivity, Chapaevsk, 
Russia.  Organohalogen Compounds 69:1388-1391. 
 
Sjordin A, McGahee EE 3rd, Focant JF, Jones RS, Lapeza CR, Zhang Y, et al. 2004.  
Semiautomated high-throughput extraction and cleanup method for the measurement of 
polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in  
human serum. Anal Chem 76:1921-1927. 
 
Sorensen K, Aksglaede L, Holm Petersen J, Juul A. 2010. Recent changes in pubertal timing in 
healthy Danish boys:  associations with body mass index.  J Clin Endocrinol Metab 95:263-270. 
 
Sun SS, Schubert CM, Liang R, Roche AF, Kulin HE, Lee PA, et al. 2005.  Is sexual maturity 
occurring earlier among U.S. children?  J Adolesc Health 37:345-355. 
 
Susman EJ, Houts RM, Steinberg L, Belsky J, Cauffman E, DeHart G, et al. 2010.  Longitudinal 
development of secondary sexual characteristics in girls and boys between ages 9½ and 15½ 
years. Arch Pediatr Adolesc Med 164:166-173. 
Page 21 of 28
 22 
 
Tanner JM, Whitehouse RH. 1976. Clinical longitudinal standards for height, weight, height 
velocity, weight velocity, and stages of puberty.  Arch Dis Child 51:170-179. 
 
Theobald HM, Kimmel GL, Peterson RE. 2003. Developmental and reproductive toxicity of 
dioxins and related chemicals.  In:  Dioxins and Health, 2nd ed (Schechter A, Gasiewicz TA, 
eds). Hoboken, New Jersey: John Wiley & Sons, Inc., 329-431.  
 
Turner W, DiPeitro E, Lapeza C, Green V, Gill J, Patterson DG Jr.  1997. A fast universal 
automated cleanup system for the isotope-dilution high-resolution mass spectrometric analysis of 
PCDDs, PCDFs, coplanar PCBs , PCB congeners, and persistent pesticides from the same serum 
sample. Organohalogen Compounds 31:26-31.  
 
Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, et al. 2006. 
Review:  the 2005 World Health Organization reevaluation of human and mammalian toxic 
equivalency factors for dioxins and dioxin-like compounds.  Toxicological Sciences 223-241. 
 
Van Lenthe FJ, Kemper CG, van Mechelen W. 1996.  Rapid maturation in adolescence results in 
greater obesity in adulthood:  the Amsterdam Growth and Health Study.  Am J Clin Nutr 64:18-
24. 
 
Williams PL, Sergeyev O, Lee MM, Korrick SA, Burns JS, Humblet O, et al. 2010.  Blood lead 
levels and delayed onset of puberty in a longitudinal study of Russian boys.  Pediatrics 
125:e1088-e1096.  
 
Wu T, Buck GM, Mendola P. 2003. Blood lead levels and sexual maturation in U.S. girls:  The 
Third National Health and Nutrition Examination Survey, 1988-1994.  Environ Health Perspect 
111:737-741. 
Page 22 of 28
 23 
Table 1:  Demographic, physical exam, and family characteristics at study entry for 
Chapaevsk boys with dioxin or PCB levels (n=473)                                          
Characteristic   Missing (N) N (%)   Mean (range)____________ 
Growth measures   
Age (years)        0     8.4 (7.8 – 9.4)  
Height (cm)       0     130 (111 - 147) 
Weight (kg)       0     27.1 (15.4 – 49.4) 
BMI (kg/m2)       0     15.9 (11.8 – 25.2) 
Overweighta       0   80 (17%) 
Underweighta       0   28 (6%)   
 
Pubertal maturation 
Tanner G2+       0  141 (30%) 
Testicular volume >3ml     4    66 (14%) 
 
Nutrition 
Calories/day (kcal)      3     2820 (884 – 5000) 
%Protein       3     11.6 (6.6 – 18.8) 
%Fat        3     33.9 (15.3 – 51.5) 
%Carbohydrate      3     54.5 (33.2 – 72.7)  
 
Birth and neonatal history 
Birth weight (kg)      3     3.34 (1.40 – 4.80) 
Low birth weight (<2500 gm)    3      24 (5%) 
Gestational age (wks)      4       39.1 (30.0 – 44.0) 
Preterm (<37 wks)      4      37 (8%) 
Duration breastfed (wks)    11     27.4 (0 – 312.0) 
 
Maternal characteristics and pregnancy exposures 
Age at birth (years)       5     23.9 (15.1 – 42.6) 
Age at menarche (years)     39     13.3 (13.0 – 17.0) 
Nulliparous      18  303 (67%) 
Maternal pregnancy smoking    13      36 (8%) 
Any household smoking      9  224 (48%) 
Maternal pregnancy alcohol    16      59 (13%) 
 
Household characteristics 
Family Income (per month)      1 
 <$175     164 (35%) 
 $175-$250    123 (26%) 
 >$250     185 (39%) 
Parental Educationb        4 
 ≤ High school      37 (8%) 
 Some college or junior college 279 (59%) 
 College graduate   153 (33%) 
 
Other exposures 
 Blood lead ≥5µg/dl     0  132 (28%) 
aOverweight (≥ 1 SD above mean BMI for age); very  underweight (≥ 2 SD below mean BMI for age) using WHO 
standards (de Onis et al. 2007).  
bMaximum of mother’s and father’s education. 
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Table 2:  Serum dioxin, furan and PCB Toxic Equivalents (pg TEQ/g lipid), and dioxin, 
furan and PCB concentrations among Chapaevsk boys at study enrollment (n=473) 
 
Organochlorine Mean ±SD   25%  50%  75%  Max_______ 
 
TEQs (pg TEQ/g lipid) 
 
TCDDa      3.1 ±3.1   1.3    2.8    3.9    44.9 
PCDD TEQ  10.6 ± 9.5   4.5    8.2  13.6    89.8 
PCDF TEQ      7.0 ± 11.2   3.0    4.2    6.9  154.3  
Co-PCB TEQb     8.1 ± 6.5   4.5    6.4    9.4    67.2 
Total TEQc  27.7 ± 22.0 14.4  21.1  33.2  174.7 
 
Concentration (pg/g lipid) 
 
PCDD   160 ± 110   96  136  188  1237 
PCDF      57 ± 78   27    39    57  1083 
Co-PCBd  209 ± 143 129  181  246  2067 
 
Concentration (ng/g lipid) 
 
ΣPCBse   331 ± 312  164   250   394   4248  
______________________________________________________________________________ 
 
aThe median limit of detection (LOD) for TCDD was 0.60 pg/g lipid; 123 (26%) of TCDD values were less than this 
LOD (Burns et al. 2009).  
 
bSum of co-planar PCB TEQs (IUPAC congeners: 77, 81, 126, 169) 
 
cSum of TEQ measures for combined dioxin, furan, co-PCB and mono-ortho-PCB congeners. 
 
dSum of co-planar PCB concentrations (IUPAC congeners: 77, 81, 126, 169) 
 
eSum of non-coplanar PCBs, n=468 (IUPAC congeners: 18, 28, 52, 49, 44, 74, 66, 101, 99, 87, 110, 118, 105, 151, 
149, 146, 153, 138/158, 128, 167, 156, 157, 178, 187, 183, 177, 172, 180, 170, 189, 201, 196/203, 195, 194, 206)  
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Table 3:  Adjusted hazard ratios (HRs)a and 95% confidence intervals for associations of quartiles 
of serum dioxins, furans, and PCBs with pubertal onset between ages 8-12 years among Chapaevsk 
boys (n=453) 
 
Adjusted HR (95% Confidence Interval) 
Organochlorine Toxic Equivalent Measures    Concentration Measures  
   Quartiles 
   TV>3mlb  G2+b   TV>3mlb  G2+b 
 
Total TEQ (pg TEQ/g lipid) 
   Q1 (< 14)  1.00   1.00   N/Ac   N/Ac  
   Q2 (14 -<20) 1.03 (0.72, 1.47) 0.80 (0.58, 1.11)   
   Q3 (20 -<30) 0.95 (0.57, 1.35) 0.90 (0.66, 1.23)      
   Q4 (30 - 175) 0.81 (0.58, 1.15) 0.91 (0.67, 1.23)  
    p- trend   0.19   0.77    
 
TCDD (pg TEQ/g lipid)d        TCDD (pg/g lipid) 
   Q1 (< 1.3)       1.00   1.00   
   Q2 (1.3 - 2.7)       0.97 (0.70, 1.34) 0.99 (0.73, 1.34 
        Q3 (2.8 - 3.9)       0.89 (0.63, 1.24) 1.03 (0.76, 1.40) 
   Q4 (4.0 - 45)       0.69 (0.48, 0.98) 1.08 (0.79, 1.48) 
   p-trend        0.04   0.60    
 
PCDD TEQ (pg TEQ/g lipid)      PCDD (pg/g lipid) 
   Q1 (< 5)  1.00   1.00   1.00   1.00 
   Q2 (5 - 7.9) 0.87 (0.62, 1.21) 0.75 (0.55, 1.03) 0.93 (0.67, 1.31) 0.92 (0.68, 1.26) 
   Q3 (8 - 12.9) 0.61 (0.43, 0.85) 0.76 (0.56, 1.03) 0.88 (0.63, 1.23) 1.06 (0.78, 1.43) 
   Q4 (13 - 90) 0.68 (0.49, 0.95) 0.92 (0.69, 1.25) 0.70 (0.50, 1.00) 1.02 (0.74, 1.39) 
   p-trend  0.006   0.64   0.05   0.70 
 
PCDF TEQ (pg TEQ/g lipid)      PCDF (pg/g lipid) 
   Q1 (< 3)  1.00   1.00   1.00   1.00 
   Q2 (3 - 3.9) 1.21 (0.85, 1.72) 0.85 (0.62, 1.18) 0.91 (0.65, 1.27) 0.90 (.067, 1.21) 
   Q3 (4 - 6.9) 1.08 (0.77, 1.52) 1.06 (0.79, 1.44) 0.88 (0.63, 1.23) 0.93 (0.69, 1.26) 
   Q4 (7 - 154) 0.86 (0.60, 1.24) 0.80 (0.58, 1.12) 0.75 (0.53, 1.06) 0.89 (0.65, 1.21) 
    p- trend   0.32   0.44   0.11   0.51 
 
co-PCB TEQ (pg TEQ/g lipid)      co-PCB (pg/g lipid) 
   Q1 (<4.5)  1.00   1.00   1.00   1.00 
   Q2 (4.5 - 6.4) 1.23 (0.88, 1.70) 1.14 (0.85, 1.54) 1.13 (0.80, 1.57) 1.04 (0.77, 1.42) 
   Q3 (6.5 - 9.4) 1.12 (0.79, 1.59) 0.97 (0.71, 1.33) 0.85 (0.60, 1.19) 0.85 (0.63, 1.16) 
   Q4 (9.5 - 67) 1.02 (0.72, 1.43) 1.02 (0.75, 1.39) 0.78 (0.67, 1.10) 0.87 (0.64, 1.18) 
   p-trend   0.88   0.84   0.08   0.24 
 
ΣPCBs (ng/g lipid)e       ΣPCBs (ng/g lipid)e    
   Q1 (< 175) N/Ac   N/Ac   1.00   1.00                                        
   Q2 (175 -<250)       1.19 (0.84, 1.69) 1.01 (0.74, 1.39) 
   Q3 (250 -<400)       1.12 (0.79, 1.58) 1.14 (0.84, 1.55) 
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   Q4 (400 - 4248)       0.97 (0.68, 1.39) 1.14 (0.83, 1.55) 
   p-trend        0.79   0.34   
_____________________________________________________________________________________ 
aAdjusted for: birth weight, gestational age, parental education, household income, 8/9-year diet (total calories, %protein, 
%fat), blood lead ≥5 µg/dl, maternal pregnancy alcohol intake, baseline height and BMI. 
 
bTesticular volume (TV)>3ml; genitalia staging ≥2 (G2+).  
 
cConcentration or TEQ measures not applicable. 
 
dTCDD TEQ is identical to TCDD concentration. 
 
en=448. 
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Figure Legend 
 
Figure 1:  Adjusted Hazard Ratios for Pubertal Onset According to Quartiles of Serum 
Levels of TCDD, Dioxins, Furans, and co-planar PCBs   
Hazard Ratios (HR) with bars denoting 95% confidence intervals for the association of serum 
quartiles of both concentrations and TEQs for dioxin (TCDD), dioxins (PCDD), furans (PCDF), 
and co-planar PCBs (co-PCBs) with risk of pubertal onset (TV>3ml) between ages 8-12 years 
among  Chapaevsk boys.  Results adjusted for:  birth weight, gestational age, parental education, 
household income, 8/9-year diet (total calories, %protein, % fat), blood lead ≥5 µg/dl, maternal 
pregnancy alcohol intake, baseline height and BMI.    
Page 27 of 28
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
H
az
ar
d
 R
at
io
Quartiles of Serum Levels
Concentration (pg/g lipid)
TEQ (pg TEQ/g lipid)
* P for trend < 0.05
*
PCDDPCDD 
TEQ
PCDFPCDF
TEQ
Co-PCBsCo-PCBs
TEQ
*
TCDD
Page 28 of 28
